Previous research has established a relationship between NCAPG2 expression levels and tumorigenesis, particularly in cancers such as breast and colorectal cancer, where its overexpression has been associated with poor prognosis and aggressive disease phenotypes [8, 9]. This evidence concerns the gene NCAPG2 and cancer.